Alvarado Silvia, MacDonald Ibo, Chanez Vivianne, Kudchadkar Sapna R, Ista Erwin, Ramelet Anne-Sylvie
Institute of Higher Education and Research in Healthcare - IUFRS, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland; Lausanne University Hospital, Department of Woman-Mother-Child, Paediatric Intensive and Intermediate Care, Switzerland.
Institute of Higher Education and Research in Healthcare - IUFRS, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Aust Crit Care. 2025 Mar;38(2):101113. doi: 10.1016/j.aucc.2024.08.009. Epub 2024 Sep 19.
Analgosedation is standard practice to ensure comfort and safety of critically ill children in paediatric intensive care units (PICUs). However, a significant number of children develop iatrogenic withdrawal syndrome or delirium with these drugs. The European Society of Paediatric and Neonatal Intensive Care published a position statement in 2016, but how successfully its recommendations have been implemented is unknown.
Following were the objectives of this study: (i) to describe assessment practices (prevalence, measurement instruments, and frequency) for pain, sedation, iatrogenic withdrawal syndrome and delirium; (ii) to assess how practices meet the position statement; and (iii) to identify organisational factors associated with the use of recommendations for pain and sedation assessment.
A secondary analysis of prospectively collected data from the multicentre prevalence study (European Prevalence of Acute Rehab for Kids in the PICU) conducted in 38 PICUs, across 15 European countries in 2018. Data from 453 children were analysed.
Of the 38 PICUs, 97% assessed pain, 89% sedation, 82% withdrawal, and 42% delirium. These four symptoms were mainly assessed and documented by the Face, Legs, Activity, Cry, Consolability scale (39%) and Numerical Rating Scale (24%) every 8, 4, or 2 h for pain; the COMFORT-B (45%) and COMFORT (24%) scales every 8 or 2 h for sedation; the Sophia Observation withdrawal Scale (37%) and Withdrawal Assessment Tool-1 (32%) scales every 8 or 4 h for withdrawal and the Cornell Assessment Pediatric-Delirium (18%) and Sophia Observation Withdrawal Symptoms-Pediatric Delirium (16%) scales every 12 or 8 h for delirium. Concordance with the position statement recommendations was low to moderate (13-69%). Adherence to recommendations were influenced by the variables of nurse-to-patient ratio, type of hospital, and the number of PICU beds.
Based on prospectively collected data, there was variability in pain and sedation assessment practices and a lack of adherence with recommendations in the EU, particularly for delirium. These findings highlight the need for more proactive dissemination, and investigation of barriers and implementation strategies to improve evidence-based assessment practices.
在儿科重症监护病房(PICUs)中,镇痛镇静是确保危重症患儿舒适与安全的标准做法。然而,相当数量的儿童使用这些药物后会出现医源性戒断综合征或谵妄。欧洲儿科和新生儿重症监护学会在2016年发表了一份立场声明,但尚不清楚其建议的实施效果如何。
本研究的目的如下:(i)描述疼痛、镇静、医源性戒断综合征和谵妄的评估实践(患病率、测量工具和频率);(ii)评估实践如何符合立场声明;(iii)确定与疼痛和镇静评估建议使用相关的组织因素。
对2018年在15个欧洲国家的38个PICUs进行的多中心患病率研究(儿科重症监护病房儿童急性康复的欧洲患病率)中前瞻性收集的数据进行二次分析。分析了453名儿童的数据。
在38个PICUs中,97%评估疼痛,89%评估镇静,82%评估戒断,42%评估谵妄。这四种症状主要通过面部、腿部、活动、哭闹、安慰度量表(39%)和数字评分量表(24%)每8、4或2小时评估一次疼痛;COMFORT - B量表(45%)和COMFORT量表(24%)每8或2小时评估一次镇静;索菲亚观察戒断量表(37%)和戒断评估工具 - 1量表(32%)每8或4小时评估一次戒断,康奈尔儿科谵妄评估量表(18%)和索菲亚观察戒断症状 - 儿科谵妄量表(16%)每12或8小时评估一次谵妄。与立场声明建议的一致性为低到中度(13 - 69%)。对建议的遵守情况受到护患比、医院类型和PICU床位数量等变量的影响。
基于前瞻性收集的数据,欧盟在疼痛和镇静评估实践方面存在差异,且对建议的遵守情况不佳,尤其是在谵妄评估方面。这些发现凸显了更积极传播以及调查障碍和实施策略以改善循证评估实践的必要性。